Depósito Digital de Documentos de la UAB Encontrados 144 registros  inicioanterior37 - 46siguientefinal  ir al registro: La búsqueda tardó 0.00 segundos. 
37.
18 p, 951.7 KB Long-Term Benefit-Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis : A Network Meta-Analysis / Armstrong, April W (Department of Dermatology. Keck School of Medicine. University of Southern California) ; Soliman, A.M. (AbbVie. Inc.) ; Betts, Keith A (Analysis Group. Inc.) ; Wang, Y. (Analysis Group. Inc.) ; Gao, Y. (Analysis Group. Inc.) ; Stakias, V. (AbbVie. Inc.) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Introduction: The long-term benefit-risk profiles of licensed and investigational treatments for moderate-to-severe plaque psoriasis have not been fully characterized. Methods: Randomized controlled trials (RCTs) of licensed and investigational treatments for moderate-to-severe plaque psoriasis were identified through a systematic literature review through 2 May 2021. [...]
2022 - 10.1007/s13555-021-00647-0
Dermatology and Therapy, Vol. 12 Núm. 1 (january 2022) , p. 167-184  
38.
9 p, 823.5 KB The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain / Maravilla-Herrera, Paulina (Weber) ; Merino, María (Weber) ; Alfonso Zamora, Santiago (Acción Psoriasis) ; Balea Filgueiras, Jesús (Complejo Hospitalario Universitario de Ferrol) ; Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Delgado Sánchez, Olga (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Dolz Sinisterra, Francisco (Hospital Universitari Doctor Peset (València)) ; García-Ruiz, Antonio (Universidad de Málaga) ; Herranz Pinto, Pedro (Hospital Universitario La Paz (Madrid)) ; Manfredi, Antonio (Acción Psoriasis) ; Martínez Olmos, José (Escuela Andaluza de Salud Pública (EASP)) ; Morales de los Ríos Luna, Paloma (Hospital General Universitario Gregorio Marañón) ; Puig Sanz, Lluís (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Ros Abarca, Sandra (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Hidalgo, Álvaro (Fundación Weber) ; Universitat Autònoma de Barcelona
Psoriasis is a chronic disease involving the skin, which significantly impacts the quality of life. Disease severity and treatment efficacy (i. e. , response) are assessed through the Psoriasis Area and Severity Index (PASI). [...]
2023 - 10.3389/fpubh.2023.1000776
Frontiers in Public Health, Vol. 11 (january 2023)  
39.
18 p, 2.0 MB Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis : Results at Week 12 from the PSoHO Study in a Real-World Setting / Lynde, Charles (Lynde Institute for Dermatology (Markham, Canadà)) ; Riedl, Elisabeth (Medical University of Vienna. Department of Dermatology) ; Maul, Julia-Tatjana (University of Zurich. Faculty of Medicine) ; Torres, Tiago (Centro Hospitalar Universitário do Porto) ; Pinter, Andreas (University Hospital Frankfurt. Department of Dermatology, Venereology and Allergology) ; Fabbrocini, Gabrielle (University of Naples Federico II. Section of Dermatology, Department of Clinical Medicine and Surgery) ; Daniele, Flavia (Medica Dermatologa en Swiss Medical Group (Buenos Aires, Argentina)) ; Brnabic, Alan (Eli Lilly and Company) ; Reed, Catherine (Eli Lilly and Company) ; Wilhelm, Stefan (Eli Lilly and Company) ; Holzkämper, Thorsten (Eli Lilly and Company) ; Schuster, Christopher (Eli Lilly and Company) ; Puig Sanz, Lluís (Institut de Recerca Sant Pau) ; Universitat Autònoma de Barcelona
In routine clinical care, important treatment outcomes among patients with moderate-to-severe plaque psoriasis (PsO) have been shown to vary according to patient demographics and disease characteristics. [...]
2023 - 10.1007/s12325-022-02379-9
Advances in Therapy, Vol. 40 (march 2023) , p. 869-886  
40.
10 p, 436.5 KB Therapeutic Drug Monitoring of Vancomycin Concentrations for the Management of Bone and Joint Infections : An Urgent Need / Rio-No, Laura (Parc de Salut MAR de Barcelona) ; Sorlí, Luisa (Universitat Pompeu Fabra. Facultat de Ciències de la Salut i de la Vida) ; Arderiu-Formentí, Alba (Parc de Salut MAR de Barcelona) ; de Antonio Ferrer, Marta (Parc de Salut MAR de Barcelona) ; Martorell, Lucas (Universitat Autònoma de Barcelona. Facultat de Medicina) ; Subirana, Isaac (Institut Hospital del Mar d'Investigacions Mèdiques) ; Puig-Verdié, Lluís (Parc de Salut MAR de Barcelona) ; Alier, Albert (Parc de Salut MAR de Barcelona) ; Gómez-Junyent, Joan (Parc de Salut MAR de Barcelona) ; Pérez-Prieto, Daniel (Parc de Salut MAR de Barcelona) ; Luque, Sonia (Parc de Salut MAR de Barcelona) ; Universitat Autònoma de Barcelona
Vancomycin is used for the treatment of bone and joint infections (BJI), but scarce information is available about its pharmacokinetic/pharmacodynamic (PK/PD) characteristics. We aimed to identify the risk factors associated with the non-achievement of an optimal PK/PD target in the first therapeutic drug monitoring (TDM). [...]
2023 - 10.3390/tropicalmed8020113
Tropical medicine and infectious disease, Vol. 8 (february 2023)  
41.
17 p, 2.5 MB Tyk2 Targeting in Immune-Mediated Inflammatory Diseases / Rusiñol, Lluís (Universitat Autònoma de Barcelona) ; Puig Sanz, Lluís (Institut de Recerca Sant Pau)
The Janus kinase (Jak)/signal transducer and activating protein (STAT) pathways mediate the intracellular signaling of cytokines in a wide spectrum of cellular processes. They participate in physiologic and inflammatory cascades and have become a major focus of research, yielding novel therapies for immune-mediated inflammatory diseases (IMID). [...]
2023 - 10.3390/ijms24043391
International journal of molecular sciences, Vol. 24 (february 2023)  
42.
16 p, 539.9 KB Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis / Iznardo, Helena (Institut de Recerca Sant Pau) ; Roé Crespo, Esther (Institut de Recerca Sant Pau) ; Serra-Baldrich, E (Institut de Recerca Sant Pau) ; Puig Sanz, Lluís (Institut de Recerca Sant Pau) ; Universitat Autònoma de Barcelona
Abrocitinib is a JAK1 selective inhibitor recently approved for the treatment of moderate-to-severe atopic dermatitis in adults. It has demonstrated efficacy and safety in several clinical trials, both in children and adults, in monotherapy, and compared with dupilumab. [...]
2023 - 10.3390/pharmaceutics15020385
Pharmaceutics, Vol. 15 (january 2023)  
43.
11 p, 652.6 KB Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type : a cross-sectional patient survey* / Mahil, Satveer K. ; Yates, Mark (King's College London) ; Langan, Sinead M. (London School of Hygiene and Tropical Medicine) ; Yiu, Zenas Z.N. ; Tsakok, Teresa ; Dand, Nick ; Mason, Kayleigh J. ; McAteer, Helen ; Meynell, Freya ; Coker, Bolaji ; Vincent, A. (Guy's and St Thomas' NHS Foundation Trust) ; Urmston, Dominic ; Vesty, Amber ; Kelly, J. (The University of Manchester) ; Lancelot, Camille (France Veterinary International) ; Moorhead, Lucy (Guy's and St Thomas' NHS Foundation Trust) ; Bachelez, Hervé (Université Paris Cité) ; Bruce, I.N. (The University of Manchester) ; Capon, Francesca (King's College London) ; Contreras, Claudia Romina (Universidad Nacional de Asunción) ; Cope, Andrew P. (Kingston College United Kingdom) ; De La Cruz, C. (University of Santiago, Chile) ; Di Meglio, Paola (Newcastle University) ; Gisondi, Paolo (University of Verona) ; Hyrich, Kimme (The University of Manchester) ; Jullien, Denis (Hospices Civils de Lyon (Centre Hospitalier Universitaire de Lyon)) ; Lambert, Julien ; Marzo-Ortega, H. (Leeds Teaching Hospitals NHS Trust) ; McInnes, Iain B. (University of Glasgow) ; Naldi, L. (San Bortolo Hospital) ; Norton, Sam (King's College London) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Sengupta, Raj (Royal National Hospital For Rheumatic Diseases NHS Foundation Trust) ; Spuls, Phyllis (University of Amsterdam) ; Torres, Tiago (Centro Hospitalar e Universitário do Porto) ; Warren, Richard B. (The University of Manchester) ; Waweru, Hoseah (Upper Hill Medical Centre) ; Weinman, John (King's College London) ; Griffiths, Chris E.M. (The University of Manchester) ; Barker, Jonathan (The Kings College) ; Brown, Matthew A. (Guy's and St Thomas' NHS Foundation Trust) ; Galloway, James B. ; Smith, Catherine (King's College London)
Background: Registry data suggest that people with immune-mediated inflammatory diseases (IMIDs) receiving targeted systemic therapies have fewer adverse coronavirus disease 2019 (COVID-19) outcomes compared with patients receiving no systemic treatments. [...]
2021 - 10.1111/bjd.19755
British journal of dermatology, Vol. 185 Núm. 1 (july 2021) , p. 80-90  
44.
5.7 MB Influencia de la articulación tibioperonea proximal en la osteotomía valguizante de cierre tibial / Sánchez Soler, Juan Francisco ; Monllau García, Juan Carlos, dir. ; Hinarejos Gómez, Pedro, dir. ; Puig Verdie, Lluís, dir.
INTRODUCCIÓ. L'osteotomia valguitzant de sostracció tibial (OVST) obliga a realitzar un gest quirúrgic associat sobre l'articulació tibioperonea proximal, ja sigui l'osteotomia del peroné proximal (OPP) o la desinserció tibioperonea proximal (DTPP). [...]
INTRODUCCIÓN. La osteotomía valguizante de sustracción tibial (OVST) obliga a realizar un gesto quirúrgico asociado sobre la articulación tibioperonea proximal, bien sea la osteotomía del peroné proximal (OPP) o la desinserción tibioperonea proximal (DTPP). [...]
INTRODUCTION. Closed wedge high tibial osteotomy (CWHTO) requires an associated surgical procedure on the proximal tibiofibular joint, either proximal fibular osteotomy (PFO) or tibiofibula joint dislocation (TFJD). [...]

2022  
45.
11 p, 528.0 KB Complete clearance and Psoriasis Area and Severity Index response for brodalumab and ustekinumab by previous treatment history in AMAGINE-2 and AMAGINE-3 / Reich, K. (Translational Research in Inflammatory Skin Diseases. Institute for Health Services Research in Dermatology and Nursing. University Medical Center Hamburg-Eppendorf) ; Hansen, Jes Birger (LEO Pharma) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Konstantinou, M.P. (Service de Dermatologie. Larrey Hospital) ; Warren, R. B. (Dermatology Centre. Salford Royal NHS Foundation Trust. Manchester NIHR Biomedical Research Centre. University of Manchester) ; Universitat Autònoma de Barcelona
Background: The pathway for treatment of psoriasis is partly dependent upon disease severity, and patients may experience inadequate response at any point along the treatment pathway. Patients who repeatedly fail therapy represent a population in whom effective and well-tolerated treatment options are limited. [...]
2021 - 10.1111/jdv.17433
Journal of the European Academy of Dermatology and Venereology, Vol. 35 Núm. 10 (october 2021) , p. 2034-2044  
46.
11 p, 1.5 MB Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis : interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up / Papp, Kim A (K Papp Clinical Research and Probity Medical Research) ; Lebwohl, M. G. (Icahn School of Medicine at Mount Sinai) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Ohtsuki, M. (Jichi Medical University) ; Beissert, Stefan (Department of Dermatology. University Hospital Carl Gustav Carus. TU Dresden) ; Zeng, J. (AbbVie Inc.) ; Rubant, S. (AbbVie Inc.) ; Sinvhal, R. (AbbVie Inc.) ; Zhao, Y. (AbbVie Inc.) ; Soliman, A.M. (AbbVie Inc.) ; Alperovich, G. (AbbVie Inc.) ; Leonardi, C. (Central Dermatology. Richmond Heights)
Background: Psoriasis is a chronic inflammatory skin disease requiring prolonged treatment. New biologic therapies require long-term evaluation to assess the durability of their efficacy and safety profiles over time. [...]
2021 - 10.1111/bjd.20595
British journal of dermatology, Vol. 185 Núm. 6 (december 2021) , p. 1135-1145  

Depósito Digital de Documentos de la UAB : Encontrados 144 registros   inicioanterior37 - 46siguientefinal  ir al registro:
Vea también: autores con nombres similares
2 PUIG, Lluis
11 Puig, L.
4 Puig, Laia
1 Puig, Ll.
2 Puig, Lluis
2 Puig, Lluís
6 Puig, Luis
1 Puig, Luis M. de
6 Puig, Luís
2 Puíg, Lluis
6 Puíg, Luis
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.